Cargando…

Bexarotene therapy ameliorates behavioral deficits and induces functional and molecular changes in very-old Triple Transgenic Mice model of Alzheimer´s disease

INTRODUCTION: Bexarotene, a retinoid X receptor agonist, improves cognition in murine models of Alzheimer’s disease (AD). This study evaluated the effects of bexarotene on pathological and electrophysiological changes in very old triple transgenic AD mice (3xTg-AD mice). METHODS: 24-month-old 3xTg-A...

Descripción completa

Detalles Bibliográficos
Autores principales:	Muñoz-Cabrera, Jonathan Mauricio, Sandoval-Hernández, Adrián Gabriel, Niño, Andrea, Báez, Tatiana, Bustos-Rangel, Angie, Cardona-Gómez, Gloria Patricia, Múnera, Alejandro, Arboleda, Gonzalo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2019
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6785083/ https://www.ncbi.nlm.nih.gov/pubmed/31596896 http://dx.doi.org/10.1371/journal.pone.0223578

Ejemplares similares

Bexarotene normalizes chemotherapy-induced myelin decompaction and reverses cognitive and sensorimotor deficits in mice
por: Chiang, Angie C. A., et al.
Publicado: (2020)

A Novel Co-Crystal of Bexarotene and Ligustrazine Improves Pharmacokinetics and Tissue Distribution of Bexarotene in SD Rats
por: Ren, Shuyue, et al.
Publicado: (2020)

A Humanin Derivative Reduces Amyloid Beta Accumulation and Ameliorates Memory Deficit in Triple Transgenic Mice
por: Niikura, Takako, et al.
Publicado: (2011)

Photodegradation of Bexarotene and Its Implication for Cytotoxicity
por: Kryczyk-Poprawa, Agata, et al.
Publicado: (2021)

Comparison of the Efficacy and Safety of Bexarotene and Photo(Chemo)Therapy Combination Therapy and Bexarotene Monotherapy for Cutaneous T-Cell Lymphoma
por: Morita, Akimichi, et al.
Publicado: (2022)

The utility of bexarotene in mycosis fungoides and Sézary syndrome
por: Panchal, Manisha R, et al.
Publicado: (2015)

Preclinical PET Neuroimaging of [(11)C]Bexarotene
por: Rotstein, Benjamin H., et al.
Publicado: (2016)

Bexarotene-Induced Hypertriglyceridemia: A Case Report
por: Maminakis, Chris, et al.
Publicado: (2018)

Transcriptomic signature of Bexarotene (Rexinoid LGD1069) on mammary gland from three transgenic mouse mammary cancer models
por: Abba, Martin C, et al.
Publicado: (2008)

Identification of Bexarotene as a PPARγ Antagonist with HDX
por: Marciano, David P., et al.
Publicado: (2015)

Development of Bexarotene Analogs for Treating Cutaneous T-Cell Lymphomas
por: Warda, Ankedo, et al.
Publicado: (2023)

Preventive Effect of Quercetin in a Triple Transgenic Alzheimer’s Disease Mice Model
por: Paula, Pérez-Corredor, et al.
Publicado: (2019)

Bexarotene Gel: A New Topical Therapy for Alopecia Areata
por: Rajiv, Mahajan, et al.
Publicado: (2010)

The emerging role of bexarotene in the treatment of Alzheimer’s disease: current evidence
por: Tousi, Babak
Publicado: (2015)

Bexarotene: A Rare Cause of Misleading Thyroid Function Tests
por: Pattan, Vishwanath, et al.
Publicado: (2020)

Cocrystal Prediction of Bexarotene by Graph Convolution Network and Bioavailability Improvement
por: Xiao, Fu, et al.
Publicado: (2022)

FRI511 Bexarotene: A Deceptive Cause Of Iatrogenic Hypothyroidism
por: Ghaith, Sarah, et al.
Publicado: (2023)

Role of Liver X Receptor in AD Pathophysiology
por: Sandoval-Hernández, Adrián G., et al.
Publicado: (2015)

Early Treatment Critical: Bexarotene Reduces Amyloid-Beta Burden In Silico
por: Rosenthal, Joseph, et al.
Publicado: (2016)

Effectiveness of combined bexarotene and excimer laser treatment for folliculotropic mycosis fungoides
por: Furukawa, Fumina, et al.
Publicado: (2021)

High-Dose Thyroid Hormone Replacement in Bexarotene-Induced Central Hypothyroidism
por: Mathews, Tony, et al.
Publicado: (2021)

Remyelination varies between and within lesions in multiple sclerosis following bexarotene
por: Brown, J. William L., et al.
Publicado: (2022)

Bexarotene improves motor function after spinal cord injury in mice
por: Wang, Xingyu, et al.
Publicado: (2023)

Naringin Dihydrochalcone Ameliorates Cognitive Deficits and Neuropathology in APP/PS1 Transgenic Mice
por: Yang, Wenjuan, et al.
Publicado: (2018)

Cornel iridoid glycoside ameliorates cognitive deficits in APP/PS1/tau triple transgenic mice by attenuating amyloid-beta, tau hyperphosphorylation and neurotrophic dysfunction
por: Yang, Cuicui, et al.
Publicado: (2020)

DNA vaccines targeting amyloid-β oligomer ameliorate cognitive deficits of aged APP/PS1/tau triple-transgenic mouse models of Alzheimer’s disease
por: Sha, Sha, et al.
Publicado: (2022)

Advanced-Stage Primary Cutaneous T-Cell Lymphoma Treated with Bexarotene and Denileukin Diftitox
por: Cervigón-González, Iván, et al.
Publicado: (2011)

Phase II study of gemcitabine and bexarotene (GEMBEX) in the treatment of cutaneous T-cell lymphoma
por: Illidge, T, et al.
Publicado: (2013)

When the dust settles: what did we learn from the bexarotene discussion?
por: Tesseur, Ina, et al.
Publicado: (2013)

Correction: Early Treatment Critical: Bexarotene Reduces Amyloid-Beta Burden In Silico
por: Rosenthal, Joseph, et al.
Publicado: (2016)

Bexarotene targets autophagy and is protective against thromboembolic stroke in aged mice with tauopathy
por: Huuskonen, Mikko T., et al.
Publicado: (2016)

Bexarotene – a novel modulator of AURKA and the primary cilium in VHL-deficient cells
por: Chowdhury, Pratim, et al.
Publicado: (2018)

Influence of the Number of Axial Bexarotene Ligands on the Cytotoxicity of Pt(IV) Analogs of Oxaliplatin
por: Nosova, Yulia N., et al.
Publicado: (2017)

Efficacy and safety of bexarotene combined with photo(chemo)therapy for cutaneous T‐cell lymphoma
por: Morita, Akimichi, et al.
Publicado: (2020)

Drug screening identifies tazarotene and bexarotene as therapeutic agents in multiple sulfatase deficiency
por: Schlotawa, Lars, et al.
Publicado: (2023)

Selenomethionine Ameliorates Neuropathology in the Olfactory Bulb of a Triple Transgenic Mouse Model of Alzheimer’s Disease
por: Zhang, Zhong-Hao, et al.
Publicado: (2016)

Long- and short-term CDK5 knockdown prevents spatial memory dysfunction and tau pathology of triple transgenic Alzheimer’s mice
por: Castro-Alvarez, John F., et al.
Publicado: (2014)

The rexinoid, bexarotene, prevents the development of premalignant lesions in MMTV-erbB2 mice
por: Li, Y, et al.
Publicado: (2008)

Bexarotene treatment does not clear β-Amyloid in an AD mouse model and Beagle dogs
por: Tesseur, Ina, et al.
Publicado: (2013)

Bexarotene Reduces Blood-Brain Barrier Permeability in Cerebral Ischemia-Reperfusion Injured Rats
por: Xu, Lu, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_g7o2h3fu0qe8pgctcvvpt2hs11